Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lange

Showing results (751-760 of 1,082) with videos related to

Pageof 109
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|June 11, 2018
Differential modulation of hepatitis C virus replication and innate immune pathways by synthetic calcitriol-analogsMaged Saleh, Christoph Welsch, Chengcong Cai, et al.
Journal of Medicinal Chemistry|January 6, 2010
Design, synthesis, biological properties, and molecular modeling investigations of novel tacrine derivatives with a combination of acetylcholinesterase inhibition and cannabinoid CB1 receptor antagonismJos H M Lange, Hein K A C Coolen, Martina A W van der Neut, et al.
The Journal of Infectious Diseases|December 8, 1998
Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosisM Koot, R van Leeuwen, R E de Goede, et al.
AIDS (London, England)|January 12, 2000
Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patientsB S Blank, P L Meenhorst, G J Weverling, et al.
The Australian and New Zealand Journal of Psychiatry|April 28, 2007
AKT1 and neurocognition in schizophreniaAndrea Poyastro Pinheiro, Richard S E Keefe, Tara Skelly, et al.
Journal of the American Chemical Society|December 20, 2011
Origin of dark-channel X-ray fluorescence from transition-metal ions in waterRobert Seidel, Samira Ghadimi, Kathrin M Lange, et al.
Behavioural Brain Research|November 16, 2010
SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in ratsN M W J de Bruin, J H M Lange, C G Kruse, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 20, 2012
Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adultsAlex P Reiner, Ethan M Lange, Nancy S Jenny, et al.
Journal of Virological Methods|August 1, 1987
Pathogenesis of HIV and its implications for serodiagnosis and monitoring of antiviral therapyJ Goudsmit, J M Lange, W J Krone, et al.
Molecular Pharmacology|October 17, 2012
Potentiation of sulfonylurea action by an EPAC-selective cAMP analog in INS-1 cells: comparison of tolbutamide and gliclazide and a potential role for EPAC activation of a 2-APB-sensitive Ca2+ influxRachel E Jarrard, Yuchen Wang, Amy E Salyer, et al.
Pageof 109

Showing results (751-760 of 1,082) with videos related to

Sort By:
Pageof 109
The Journal of Steroid Biochemistry and Molecular Biology|June 11, 2018
Differential modulation of hepatitis C virus replication and innate immune pathways by synthetic calcitriol-analogsMaged Saleh, Christoph Welsch, Chengcong Cai, et al.
Journal of Medicinal Chemistry|January 6, 2010
Design, synthesis, biological properties, and molecular modeling investigations of novel tacrine derivatives with a combination of acetylcholinesterase inhibition and cannabinoid CB1 receptor antagonismJos H M Lange, Hein K A C Coolen, Martina A W van der Neut, et al.
The Journal of Infectious Diseases|December 8, 1998
Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosisM Koot, R van Leeuwen, R E de Goede, et al.
AIDS (London, England)|January 12, 2000
Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patientsB S Blank, P L Meenhorst, G J Weverling, et al.
The Australian and New Zealand Journal of Psychiatry|April 28, 2007
AKT1 and neurocognition in schizophreniaAndrea Poyastro Pinheiro, Richard S E Keefe, Tara Skelly, et al.
Journal of the American Chemical Society|December 20, 2011
Origin of dark-channel X-ray fluorescence from transition-metal ions in waterRobert Seidel, Samira Ghadimi, Kathrin M Lange, et al.
Behavioural Brain Research|November 16, 2010
SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in ratsN M W J de Bruin, J H M Lange, C G Kruse, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 20, 2012
Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adultsAlex P Reiner, Ethan M Lange, Nancy S Jenny, et al.
Journal of Virological Methods|August 1, 1987
Pathogenesis of HIV and its implications for serodiagnosis and monitoring of antiviral therapyJ Goudsmit, J M Lange, W J Krone, et al.
Molecular Pharmacology|October 17, 2012
Potentiation of sulfonylurea action by an EPAC-selective cAMP analog in INS-1 cells: comparison of tolbutamide and gliclazide and a potential role for EPAC activation of a 2-APB-sensitive Ca2+ influxRachel E Jarrard, Yuchen Wang, Amy E Salyer, et al.
Pageof 109